nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—PTK2B—blood plasma—bipolar disorder	0.0868	0.154	CbGeAlD
Leflunomide—DHODH—Pyrimidine metabolism—DPYD—bipolar disorder	0.0623	0.143	CbGpPWpGaD
Leflunomide—CYP1A2—urine—bipolar disorder	0.0511	0.0906	CbGeAlD
Leflunomide—CYP2C9—urine—bipolar disorder	0.0485	0.086	CbGeAlD
Leflunomide—DHODH—thyroid gland—bipolar disorder	0.0485	0.086	CbGeAlD
Leflunomide—AHR—adrenal cortex—bipolar disorder	0.0362	0.0643	CbGeAlD
Leflunomide—DHODH—brain—bipolar disorder	0.0312	0.0553	CbGeAlD
Leflunomide—PTK2B—thyroid gland—bipolar disorder	0.0307	0.0545	CbGeAlD
Leflunomide—CYP1A2—blood plasma—bipolar disorder	0.0266	0.0473	CbGeAlD
Leflunomide—PTK2B—nervous system—bipolar disorder	0.0258	0.0458	CbGeAlD
Leflunomide—CYP2C9—blood plasma—bipolar disorder	0.0253	0.0449	CbGeAlD
Leflunomide—AHR—thyroid gland—bipolar disorder	0.0252	0.0448	CbGeAlD
Leflunomide—PTK2B—cerebellum—bipolar disorder	0.0243	0.0431	CbGeAlD
Leflunomide—DHODH—Nucleotide metabolism—DPYD—bipolar disorder	0.0243	0.0556	CbGpPWpGaD
Leflunomide—AHR—cerebellum—bipolar disorder	0.02	0.0355	CbGeAlD
Leflunomide—PTK2B—brain—bipolar disorder	0.0197	0.035	CbGeAlD
Leflunomide—AHR—Integrated Breast Cancer Pathway—IMPA1—bipolar disorder	0.0189	0.0432	CbGpPWpGaD
Leflunomide—AHR—brain—bipolar disorder	0.0162	0.0288	CbGeAlD
Leflunomide—ABCG2—adrenal cortex—bipolar disorder	0.0141	0.0249	CbGeAlD
Leflunomide—PTK2B—Alpha-synuclein signaling—SLC6A3—bipolar disorder	0.0128	0.0293	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—NR1D1—bipolar disorder	0.0111	0.0254	CbGpPWpGaD
Leflunomide—ABCG2—thyroid gland—bipolar disorder	0.00979	0.0174	CbGeAlD
Leflunomide—CYP1A2—thyroid gland—bipolar disorder	0.00942	0.0167	CbGeAlD
Leflunomide—PTK2B—Integrins in angiogenesis—PIK3C2A—bipolar disorder	0.00907	0.0208	CbGpPWpGaD
Leflunomide—PTK2B—IL-7 Signaling Pathway—GSK3B—bipolar disorder	0.00842	0.0193	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—GATA3—bipolar disorder	0.00831	0.019	CbGpPWpGaD
Leflunomide—ABCG2—Fluoropyrimidine Activity—DPYD—bipolar disorder	0.00781	0.0179	CbGpPWpGaD
Leflunomide—ABCG2—cerebellum—bipolar disorder	0.00775	0.0138	CbGeAlD
Leflunomide—AHR—Circadian rythm related genes—CLOCK—bipolar disorder	0.00752	0.0172	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—TPH2—bipolar disorder	0.00733	0.0168	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—ADCY2—bipolar disorder	0.0072	0.0165	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—ADCY2—bipolar disorder	0.00711	0.0163	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—GSK3A—bipolar disorder	0.0071	0.0163	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	0.00693	0.0159	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—IMPA2—bipolar disorder	0.00679	0.0156	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—NRG1—bipolar disorder	0.00636	0.0146	CbGpPWpGaD
Leflunomide—ABCG2—brain—bipolar disorder	0.00629	0.0112	CbGeAlD
Leflunomide—PTK2B—TCR Signaling Pathway—GATA3—bipolar disorder	0.00612	0.014	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—SLC6A4—bipolar disorder	0.00586	0.0134	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—DRD1—bipolar disorder	0.00586	0.0134	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—GRIN1—bipolar disorder	0.00577	0.0132	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—DRD3—bipolar disorder	0.00568	0.013	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—DRD4—bipolar disorder	0.00551	0.0126	CbGpPWpGaD
Leflunomide—CYP1A2—Methylation—COMT—bipolar disorder	0.0054	0.0124	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—NR3C1—bipolar disorder	0.00533	0.0122	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—DRD2—bipolar disorder	0.00513	0.0118	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—ADM—bipolar disorder	0.00468	0.0107	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—NTRK1—bipolar disorder	0.00465	0.0106	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—IMPA1—bipolar disorder	0.00459	0.0105	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NTRK2—bipolar disorder	0.00409	0.00936	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—INS—bipolar disorder	0.00405	0.00927	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—GSK3B—bipolar disorder	0.00397	0.00909	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NDUFV2—bipolar disorder	0.0039	0.00893	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.0039	0.00893	CbGpPWpGaD
Leflunomide—ABCG2—Fluoropyrimidine Activity—MTHFR—bipolar disorder	0.00389	0.0089	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—GRIN2B—bipolar disorder	0.0038	0.0087	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—AKR1C4—bipolar disorder	0.00378	0.00865	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NR1D1—bipolar disorder	0.00339	0.00777	CbGpPWpGaD
Leflunomide—CYP1A2—Estrogen metabolism—COMT—bipolar disorder	0.00337	0.00772	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NTRK1—bipolar disorder	0.00333	0.00763	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NCAN—bipolar disorder	0.00325	0.00743	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—SLC5A3—bipolar disorder	0.00318	0.00728	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—BDNF—bipolar disorder	0.00305	0.00699	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—GSK3B—bipolar disorder	0.00289	0.00663	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CLOCK—bipolar disorder	0.0023	0.00526	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—MAOA—bipolar disorder	0.00229	0.00524	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-E—bipolar disorder	0.00228	0.00523	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—TSHB—bipolar disorder	0.00224	0.00513	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—TPH2—bipolar disorder	0.00224	0.00513	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CACNB2—bipolar disorder	0.00224	0.00513	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL1B—bipolar disorder	0.00222	0.00509	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—DPYD—bipolar disorder	0.0022	0.00505	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—GSK3B—bipolar disorder	0.00207	0.00475	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CACNA1C—bipolar disorder	0.00205	0.00469	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PIK3C2A—bipolar disorder	0.002	0.00457	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1B—bipolar disorder	0.00192	0.0044	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00191	0.00438	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—SNAP25—bipolar disorder	0.00179	0.0041	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00178	0.00408	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MB21D1—bipolar disorder	0.00176	0.00402	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ADCY2—bipolar disorder	0.00158	0.00363	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00152	0.00348	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.0015	0.00344	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—COMT—bipolar disorder	0.00136	0.00311	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—MAOA—bipolar disorder	0.00135	0.00309	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00121	0.00278	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKR1C4—bipolar disorder	0.0011	0.00252	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—IMPA2—bipolar disorder	0.0011	0.00252	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.0011	0.00252	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—MTHFR—bipolar disorder	0.0011	0.00251	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00104	0.00237	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DGKH—bipolar disorder	0.00101	0.00232	CbGpPWpGaD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000973	0.00223	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—COMT—bipolar disorder	0.000947	0.00217	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD5—bipolar disorder	0.000925	0.00212	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RGS4—bipolar disorder	0.000907	0.00208	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—bipolar disorder	0.000897	0.00205	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—POMC—bipolar disorder	0.000877	0.00201	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—INS—bipolar disorder	0.000873	0.002	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000832	0.00191	CbGpPWpGaD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000832	0.00191	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000789	0.00181	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—GSK3A—bipolar disorder	0.000777	0.00178	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	0.000764	0.00175	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-E—bipolar disorder	0.000746	0.00171	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—IMPA1—bipolar disorder	0.000742	0.0017	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ADCY2—bipolar disorder	0.000713	0.00163	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TRPC3—bipolar disorder	0.000701	0.00161	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.000693	0.00159	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000674	0.00154	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADM—bipolar disorder	0.000669	0.00153	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TSHB—bipolar disorder	0.000652	0.00149	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PDE4B—bipolar disorder	0.000652	0.00149	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TACR1—bipolar disorder	0.000652	0.00149	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—COMT—bipolar disorder	0.000648	0.00149	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—MAOA—bipolar disorder	0.000644	0.00147	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—COMT—bipolar disorder	0.00064	0.00146	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NDUFV2—bipolar disorder	0.000631	0.00145	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000623	0.00143	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—S100B—bipolar disorder	0.000621	0.00142	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKR1C4—bipolar disorder	0.000611	0.0014	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.000592	0.00136	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—IMPA2—bipolar disorder	0.000555	0.00127	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—COMT—bipolar disorder	0.000554	0.00127	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000551	0.00126	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—MAOA—bipolar disorder	0.00055	0.00126	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NR1D1—bipolar disorder	0.000549	0.00126	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—NRG1—bipolar disorder	0.000548	0.00126	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000547	0.00125	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—COMT—bipolar disorder	0.000547	0.00125	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR1A—bipolar disorder	0.00054	0.00124	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000532	0.00122	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TAC1—bipolar disorder	0.000531	0.00122	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NCAN—bipolar disorder	0.000525	0.0012	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR2C—bipolar disorder	0.000521	0.00119	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD1—bipolar disorder	0.000521	0.00119	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SLC5A3—bipolar disorder	0.000514	0.00118	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NTRK2—bipolar disorder	0.000507	0.00116	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD3—bipolar disorder	0.000505	0.00116	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GSK3A—bipolar disorder	0.000502	0.00115	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD4—bipolar disorder	0.00049	0.00112	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—IMPA2—bipolar disorder	0.000474	0.00109	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADCY2—bipolar disorder	0.000461	0.00106	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TCF7L2—bipolar disorder	0.00046	0.00105	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD2—bipolar disorder	0.000456	0.00105	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000422	0.000966	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—POMC—bipolar disorder	0.000419	0.00096	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NTRK1—bipolar disorder	0.000413	0.000946	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—S100B—bipolar disorder	0.000402	0.00092	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—GSK3B—bipolar disorder	0.000398	0.000912	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—IMPA1—bipolar disorder	0.000375	0.000858	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CLOCK—bipolar disorder	0.000372	0.000852	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000366	0.000839	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TSHB—bipolar disorder	0.000362	0.00083	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TPH2—bipolar disorder	0.000362	0.00083	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CACNB2—bipolar disorder	0.000362	0.00083	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.00036	0.000825	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—POMC—bipolar disorder	0.000358	0.00082	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—DPYD—bipolar disorder	0.000357	0.000817	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NRG1—bipolar disorder	0.000355	0.000812	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CACNA1C—bipolar disorder	0.000331	0.000759	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PIK3C2A—bipolar disorder	0.000323	0.00074	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—IMPA1—bipolar disorder	0.00032	0.000734	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR2A—bipolar disorder	0.00032	0.000732	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NDUFV2—bipolar disorder	0.000319	0.00073	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000313	0.000717	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKR1C4—bipolar disorder	0.000309	0.000707	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—bipolar disorder	0.000293	0.000671	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SNAP25—bipolar disorder	0.00029	0.000664	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NR1D1—bipolar disorder	0.000277	0.000635	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NDUFV2—bipolar disorder	0.000272	0.000624	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NCAN—bipolar disorder	0.000265	0.000607	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKR1C4—bipolar disorder	0.000264	0.000604	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC5A3—bipolar disorder	0.00026	0.000595	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GSK3B—bipolar disorder	0.000257	0.000589	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADCY2—bipolar disorder	0.000256	0.000587	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—POMC—bipolar disorder	0.000255	0.000585	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—INS—bipolar disorder	0.000254	0.000581	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NR1D1—bipolar disorder	0.000237	0.000543	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NCAN—bipolar disorder	0.000227	0.000519	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC5A3—bipolar disorder	0.000222	0.000508	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—COMT—bipolar disorder	0.00022	0.000503	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MAOA—bipolar disorder	0.000218	0.000499	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CLOCK—bipolar disorder	0.000188	0.00043	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TPH2—bipolar disorder	0.000183	0.000419	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TSHB—bipolar disorder	0.000183	0.000419	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CACNB2—bipolar disorder	0.000183	0.000419	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DPYD—bipolar disorder	0.00018	0.000412	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MTHFR—bipolar disorder	0.000177	0.000406	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CACNA1C—bipolar disorder	0.000167	0.000383	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	0.000163	0.000374	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000161	0.000369	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CLOCK—bipolar disorder	0.000161	0.000368	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TPH2—bipolar disorder	0.000156	0.000358	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TSHB—bipolar disorder	0.000156	0.000358	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CACNB2—bipolar disorder	0.000156	0.000358	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DPYD—bipolar disorder	0.000154	0.000352	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SNAP25—bipolar disorder	0.000146	0.000335	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CACNA1C—bipolar disorder	0.000143	0.000328	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—POMC—bipolar disorder	0.000142	0.000325	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—INS—bipolar disorder	0.000141	0.000323	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	0.000139	0.000319	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000138	0.000315	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADCY2—bipolar disorder	0.00013	0.000297	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SNAP25—bipolar disorder	0.000125	0.000286	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—COMT—bipolar disorder	0.000111	0.000254	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADCY2—bipolar disorder	0.000111	0.000253	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MAOA—bipolar disorder	0.00011	0.000252	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—COMT—bipolar disorder	9.48e-05	0.000217	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MAOA—bipolar disorder	9.41e-05	0.000216	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MTHFR—bipolar disorder	8.96e-05	0.000205	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MTHFR—bipolar disorder	7.66e-05	0.000175	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—POMC—bipolar disorder	7.17e-05	0.000164	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—INS—bipolar disorder	7.13e-05	0.000163	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—POMC—bipolar disorder	6.13e-05	0.00014	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—INS—bipolar disorder	6.09e-05	0.00014	CbGpPWpGaD
